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A TATA binding protein regulatory network<p>A portion of the assembly pr cess involving the regulation of the TATA binding protein (TBP) throughout the yeast genome is modeled and ex e me tally t st d.</p>
Abstract
Background: Eukaryotic genes are controlled by proteins that assemble stepwise into a
transcription complex. How the individual biochemically defined assembly steps are coordinated
and applied throughout a genome is largely unknown. Here, we model and experimentally test a
portion of the assembly process involving the regulation of the TATA binding protein (TBP)
throughout the yeast genome.
Results: Biochemical knowledge was used to formulate a series of coupled TBP regulatory
reactions involving TFIID, SAGA, NC2, Mot1, and promoter DNA. The reactions were then linked
to basic segments of the transcription cycle and modeled computationally. A single framework was
employed, allowing the contribution of specific steps to vary from gene to gene. Promoter binding
and transcriptional output were measured genome-wide using ChIP-chip and expression
microarray assays. Mutagenesis was used to test the framework by shutting down specific parts of
the network.
Conclusion: The model accounts for the regulation of TBP at most transcriptionally active
promoters and provides a conceptual tool for interpreting genome-wide data sets. The findings
further demonstrate the interconnections of TBP regulation on a genome-wide scale.
Background
The model eukaryotic cell Saccharomyces cerevisiae runs its
life with approximately 5,700 genes [1,2]. In any given envi-
ronment, each gene is expressed at a level that allows the cell
to function optimally in that environment. Most genes are
lowly expressed and relatively few are highly expressed,
which characterizes two ends of an expression continuum [3].
Several general regulatory features dictate the expression lev-
els of every gene [4-6]. First, promoter regions are packaged
into chromatin, which regulates promoter accessibility. Sec-
ond, sequence-specific DNA binding proteins orchestrate the
remodeling of chromatin and the recruitment of the tran-
scription machinery. Third, general transcription initiation
factors (GTFs) such as TFIIA, -B, -D, -E, -F, -H and RNA
polymerase II (pol II) assemble into a transcription pre-initi-
ation complex (PIC). Fourth, pol II and associated elongation
factors produce an RNA transcript. Each level of regulation
involves many proteins.
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teins regulating RNA production at thousands of genes will
require millions of coupled reaction steps. Defining these
steps has been a longstanding and continuing effort in tran-
scription biochemistry. A major challenge is piecing together
individual steps, defined in isolation, into a biochemical gene
regulatory network that describes the totality of a gene
expression program in vivo. Such a network allows aspects of
gene regulatory programs to be modeled computationally,
providing a guide for conceptualizing and predicting the com-
plex interplay of regulatory proteins.
The biochemical networks described here differ from previ-
ously described genetic networks [7,8]. The latter are typi-
cally DNA-centered and describe the spatial and temporal
aspects of organismal development as a consequence of an
unfolding cascade of chronological gene expression events
that control downstream events. Here, biochemical networks
are protein-centered, describing transcriptional control in
terms of differential equations governing the dynamic inter-
play among proteins and promoter DNA. The two are related
in that biochemical networks drive genetic networks. How-
ever, no biochemical model of a global gene regulation net-
work currently exists, and no paradigm exists by which a
biochemical model can be tested on a genome-wide scale.
Towards this goal, we have constructed a prototype model
that describes one section of the global network in terms of a
composite of well-defined biochemical interactions that regu-
late the function of the TATA binding protein (TBP). From
this model, we formally define a reaction mechanism involv-
ing interactions among TBP, its regulators, and promoter
DNA, ultimately culminating in PIC assembly and RNA pro-
duction. This formulation is analogous to a mechanism
describing a series of coupled enzymatic reactions and, thus,
can be computed using a software simulator of enzymatic
reactions. The simulator reports steady-state levels of inter-
mediates in PIC assembly and the amount of RNA produced.
Perturbations to the network are modeled computationally,
and tested experimentally via genetic mutations in the net-
work. This work provides an initial framework for developing
and testing biochemically based transcriptional regulatory
networks that govern PIC assembly and RNA output, and a
means for understanding their design logic.
Results and discussion
A model of the TBP regulatory network
The building block for modeling our global biochemical gene
regulatory network is an elementary reaction step such as:
Px + Dy → PxDy
where a protein (P) whose identity is 'x' (for example, TBP)
binds to DNA (D) located in the promoter of gene 'y' to form
a protein-DNA complex (PxDy), as demonstrated previously
[9-11]. The forward flux of P and D through the reaction is
governed by a gene-specific flux constant k1. PxDy may be cou-
pled to a second reaction step such as:
PxDy + Pz → PxDyPz
exemplified by a TBP·DNA complex binding the TBP regula-
tor called negative cofactor 2 (NC2). Examples of other types
of reaction steps include protein-protein assembly, protein-
DNA disassembly, rearrangements within a complex, and
chemical catalysis.
In principle, hundreds of different transcription regulatory
proteins can act upon each other and upon thousands of
genes, giving a nearly infinite combination of potential reac-
tion steps. In reality, biologically relevant interactions have
specificity, which keeps the number of reaction steps to a
finite but nevertheless large number. In constructing a bio-
chemical gene regulatory network, we employed only reaction
steps that have strong experimental support. TBP regulatory
mechanisms are among the best characterized eukaryotic
gene regulatory systems [12-14], and thus are ideally suited
for integrative modeling studies.
Figure 1 illustrates the prototype TBP regulatory network
upon which our studies are based. The model attempts to
assimilate a variety of individual TBP regulatory mechanisms
into a common regulatory network that is potentially applica-
ble to all genes. This represents the first description of an
integrated TBP regulatory mechanism. The model serves as a
visual framework for interpreting in vivo promoter occu-
pancy and gene expression data. While parts of the model
could be wrong or incomplete, it serves as a useful starting
point to evaluate whether potential gene regulatory mecha-
nisms defined in vitro with purified components can be inte-
grated into a network of coupled reactions that account for
transcription factor occupancy and gene expression profiles
in vivo on a genome-wide scale. The goal here is to take a step
towards bridging a myriad of in vitro biochemical mecha-
nisms with genome-scale in vivo regulatory processes, rather
than to establish a rigorous mathematical model for regula-
tory networks.
In this model, TBP resides as a self-inhibited dimer when not
bound to DNA (segments 2 and 3 in Figure 1) [9,15]. Dissoci-
ation into monomers, as directed by promoter-specific regu-
lators, is required for DNA binding. When TBP resides in the
multisubunit TFIID complex, it may also engage in interac-
tions with other TFIID subunits such as the TBP-associated
Factor 1 (TAF1) amino-teminal domain (TAND) (segment 1 in
Figure 1) [16,17]. TAND has the potential to act negatively by
blocking TBP's DNA binding surface, and positively by tether-
ing TBP to TFIID. Although not shown in the model, pro-
moter-bound regulators modulate the assembly of TFIID-
TBP at promoters [18,19], giving rise to promoter-specific
control of the network.Genome Biology 2007, 8:R46

















nThe model shows TBP assembling onto promoter regions via
three possible pathways. One pathway involves TFIID (seg-
ment 4) and a second involves the Spt-Ada-Gcn5-Acetyl-
transferase complex termed SAGA (segments 5,6). Both lead
to formation of a PIC containing TBP, pol II, and many other
transcription proteins (segments 12 and14). The PIC pro-
duces a transcribing pol II from which RNA is made (seg-
ments 13 and 15). The third pathway, outlined in more detail
below, is a nonproductive one.
TFIID and SAGA are compositionally and functionally related
complexes [20,21]. In principle, a given promoter can utilize
either the TFIID or SAGA pathway [22]. The SAGA pathway
is tailored towards TATA-containing promoters, whereas the
TFIID pathway plays a greater role at TATA-less promoters
[23].
Inhibiting the SAGA pathway (but not the TFIID pathway)
are two negative regulators of TBP, termed NC2 and Mot1
(Figure 1, segments 8, 9, and 10) [22,24]. NC2 binds to a TBP-
DNA complex and blocks PIC assembly [25,26]. Mot1 uses the
energy of ATP hydrolysis to dissociate TBP from DNA
[11,27,28]. Mot1 can also dissociate TBP from DNA in the
presence of NC2 [24], and NC2 stimulates TBP-Mot1 interac-
tions [29]. Since the genome-wide gene expression profile of
an NC2 mutant is very similar to the expression profiles of
Mot1 mutants (Figure S1 of Additional data file 1) [30,31], we
make the simplifying assumption that the two largely work
together. Consistent with the notion that Mot1 dissociates
TBP-NC2 complexes, Mot1 mutants result in the accumula-
tion of TBP-NC2 complexes in vivo [32]. However, we do not
exclude the possibility that Mot1 might act in the absence of
NC2 at some promoters.
An integrated prototype of the TBP regulatory networkFigur  1
An integrated prototype of the TBP regulatory network. Three parallel assembly pathways proceed temporally from left to right along line segments that 
represent promoter DNA. Two pathways, directed by the multisubunit TFIID complex ('D', in cyan) and the compositionally related SAGA complex ('S', in 
green) lead to productive pre-initiation complex (PIC) assembly, which goes on to produce RNA. The RNA ultimately is degraded leading to a steady-state 
balance between production and degradation. In this model, TBP ('T', in yellow) resides as a self-inhibited dimer when not bound to DNA. Dissociation 
into monomers is required for DNA binding. The TAND domain of TFIID's TAF1 subunit further inhibits TBP binding to DNA along the TFIID pathway. 
The third pathway loads TBP onto promoter DNA in a nonproductive manner, and interferes with PIC assembly unless dissociated by the combined 
action of NC2 and Mot1 ('N' and 'M' in red) [24]. NC2 and Mot1 also dissociate TBP loaded via the SAGA pathway. While Mot1 dissociates TBP in the 
absence of NC2 in vitro, it appears to be linked to NC2 function in vivo (Figure S1 in Additional data file 1). Numbers correspond to steps defined in Figure 
2a. The presence of chromatin and general transcription regulators is implicit and not shown because their contributions to PIC assembly are not being 
tested here.Genome Biology 2007, 8:R46
R46.4 Genome Biology 2007,     Volume 8, Issue 4, Article R46       Huisinga and Pugh http://genomebiology.com/2007/8/4/R46The third TBP assembly pathway is nonproductive (Figure 1,
segment 7), as has been proposed by Dasgupta et al. [33]. This
nonproductive pathway has the potential to compete with the
two productive pathways and inhibit transcription. At genes
where this nonproductive pathway limits transcriptional out-
put, removal of the inactive TBP by the coordinate action of
NC2 and Mot1 (Figure 1, segments 11, 9, and 10) would, there-
fore, result in positive regulation [33]. At genes where the
SAGA pathway dominates, NC2 and Mot1 would act nega-
tively. Thus, the model has the capacity to account for positive
and negative regulation by NC2 and Mot1, both of which have
been reported for these proteins [30,31]. The model is limited
in that it does not include other types of regulatory functions
that SAGA (Spt3), Mot1, or other network components might
be involved in [34], but for which there is no direct biochem-
ical support.
Biological systems are a balance of assembly and disassembly
processes that typically move along different pathways. Thus,
PIC disassembly and RNA degradation do not proceed by an
exact reversal of PIC assembly and transcription. Neverthe-
less, proteins and RNA are recycled, allowing gene expression
to reach a steady-state in a stable environment. Therefore,
our modeled biochemical gene regulatory network is
designed to reach steady-state, where the rate of PIC assem-
bly and RNA production equals the rate of PIC disassembly
and RNA degradation (Figure 1, segment 16).
Within the cell, the TBP regulatory network is embedded
within the larger global gene regulatory network involving
hundreds of functionally diverse proteins, such as activators,
chromatin remodeling complexes, mediator, and general
transcription factors. They are not an explicit part of this
modeling study (and thus not shown in Figure 1) because they
are assumed to make contributions to PIC assembly and RNA
output that are approximately equivalent in the mutant and
wild-type strains used here. For example, a TBP mutation
that impairs TBP-NC2 interactions is assumed to have a neg-
ligible effect on other types of interactions within chromatin
and the transcription machinery.
Computational simulation of a TBP regulatory 
network
The core mechanism, as defined by the model, is tailored to
specific genes by adjusting the flux constants. For example,
the flux constant governing the association of TBP with one
promoter may be different to the flux constant governing TBP
association with a different promoter as dictated by pro-
moter-bound activators [35-37]. In our modeling studies,
promoter-specific factors such as bound regulatory proteins
and chromatin structure are not individually defined because
their individual contributions are not being tested here. The
flux constants reflect their combined contributions.
The model illustrated in Figure 1 was converted into a series
of explicitly defined reaction segments (Figure 2a) that were
suitable for computational modeling using the freely available
KinTekSim simulator [38]. KinTekSim is a derivative of KIN-
SIM, which is used to model enzyme reaction mechanisms
[39]. For any set of similarly behaving genes, the core mecha-
nism contains 16 segments governed by 16 forward and
reverse 'flux constants'. Although written as explicit reaction
steps, these segments are intended to approximate relevant
portions of the modeled network that have been biochemi-
cally demonstrated. The flux constants provide a means for
governing the relative distribution of components in the path-
way when the simulation has reached steady-state.
The distinct arrangement of promoter elements and bound
proteins ranging from activators to chromatin is expected to
control the flow of components through every step in the net-
work (that is, flux constants) in a way that is unique to every
gene or set of co-regulated genes. This includes segments of
the mechanism that are not explicitly marked in Figure 1 as
involving promoter-bound regulators (for example, segments
1-3).
One challenge is fitting the model to experimental data within
the constraints imposed by the experimental system. We
required our computational model to report outputs that had
experimental counterparts such as promoter occupancy from
ChIP-chip assays or mRNA levels. Experimentally, such abso-
lute levels obtained on a genome-wide scale are inherently
noisy. Noise is reduced substantially by measuring changes in
occupancy or changes in mRNA levels. Therefore, we set up
our model to report both steady-state and changes in steady-
state levels when a portion of the network is shut down. Com-
putationally, we shut down a portion of the network by reduc-
ing the flux constant governing that portion of the network.
Mutagenesis is used to achieve the physiological counterpart
(see below). Further noise reduction is achieved by combin-
ing data within a set of similarly behaving genes so that hun-
dreds of measurements contribute to the modeled data.
Combining data also reduces the computational complexity
from approximately 5,700 core mechanisms for approxi-
mately 5,700 genes to a manageable small number.
Figure 2b (left panel) demonstrates how initialization of the
flux parameters governing one gene (or group of co-regulated
genes) leads the simulator to produce promoter occupancy
intermediates and RNA outputs (in arbitrary units) that have
experimental counterparts measurable with ChIP-chip and
expression microarrays. By altering flux constants that gov-
ern the progress of the coupled reactions, we control the
steady-state levels of these components.
Changing the values of the flux constants, mimicking either
gene control or genetic mutations that impair an interaction,
leads to changes in factor occupancy and RNA output. Figure
2b (right panel) plots simulated changes in RNA output (log2
scale) when one or more flux values are altered. In some cases
the impact is substantial, while in others the impact isGenome Biology 2007, 8:R46

















nminimal, reflecting the extent to which a TBP regulatory
interaction contributes to the expression of that gene.
Using this approach, we tested the simulator and the model
by creating mutant yeast strains having single and multiple
defects in biochemically defined TBP regulatory interactions
Simulation of the TBP regulatory networkFig re 2
Simulation of the TBP regulatory network. (a) The reaction mechanism as entered into the KinTekSim program. Each numbered line represents a reaction 
segment governing TBP regulation and PIC assembly shown in Figure 1. The '= =' denotes forward and reverse reactions governed by 16 forward and 16 
reverse "flux constants". See Additional data file 1 for definitions of terms. (b) Simulated output. The simulator was initiated with a set of values for species 
concentrations and flux constants governing each numbered reaction segment in (a) (in this example we used values from cluster 5 described below). The 
simulation was run to steady-state. The reported steady-state concentrations of the indicated protein-promoter complexes (gray bars, left graph) and 
RNA (black bar, left graph) are plotted as output in arbitrary units. In the right bar graph, the indicated flux constants governing the reaction segments 
defined in panel (a) were reduced to mimic the physiological effect of a mutation. Changes in RNA output resulting from the perturbation are plotted on a 
log2 scale, as is common for expression profiling. (c) Experimental design for probing the TBP regulatory network. The left illustration is an outline of TBP 
with the approximate location of amino acids targeted for mutagenesis, and the interactions that are affected. The right illustration describes the strain 
design. Four basic strains derived from Y13.2 were constructed that contained or lacked the TAF1 TAND domain (TFIID pathway) and contained or 
lacked SPT3 (SAGA pathway). A plasmid expressing the indicated HA-tagged TBP mutants under the control of the GAL10 promoter was introduced into 
each strain, with the exception that the TFIIA-interaction mutants were introduced only into the WT and taf1(ΔTAND) strains. TBP plasmids in the spt3Δ 
strains utilized the 2 micron origin. Since full galactose induction requires SAGA (Spt3), it was necessary to employ the 2 micron high copy plasmid and a 
longer induction period in the spt3Δ strains to achieve TBP expression levels comparable to those in wild-type SPT3 strains. These procedural 
modifications did not alter the experimental outcomes, except to provide quantitatively more robust effects (data not shown). Evidence that the TBP 
mutations affect the targeted interactions is provided in section 2 of Additional data file 1.
(a)
TBP auto-inhibition
1 IFT == FT
2 FTFT == FT + FT
3 TT == T + T
Promoter binding
4 FT + P == FTP
5 S + T == ST
6 ST + P == STP
7 T + P == TP
Inhibition by NC2 and Mot1
8 STP + N == NTP + S
9 NTP + M == MNTP
10 MNTP == M + N + T + P
11 TP + N == NTP
PIC assembly and transcription
12 FTP == PIC1
13 PIC1 == RNA + FT + P
14 STP == PIC2
15 PIC2 == RNA + S + T + P
16 RNA == X
Steady-state output
Initial conditions






μGenome Biology 2007, 8:R46
R46.6 Genome Biology 2007,     Volume 8, Issue 4, Article R46       Huisinga and Pugh http://genomebiology.com/2007/8/4/R46(Figure 2c, and section 1 of Additional data file 1). These
mutations provide the physiological counterpart to perturba-
tions of the computational network. The experimental design
has several constraints. First, we wanted to minimize poten-
tial indirect effects from physiological adjustments arising
from long-term exposure to the mutations. Therefore, we
placed all TBP mutants under control of the GAL10 promoter
and analyzed gene expression changes throughout the
genome after induction of TBP with galactose. TBP levels pre-
and post-induction along with endogenous wild-type TBP are
shown in Additional data file 1 (section 1 of Figure S2). The
reference state in all experiments is a strain where a 'null' TBP
is induced. Induction of wild-type TBP had no significant
effect on the system, indicating that the measured effects are
unlikely to be inherent in the experimental design and thus
are likely to be caused by the mutations.
Second, because TBP is essential for cell growth it was neces-
sary to include endogenous wild-type TBP in all strains. Com-
petition between the mutant and wild-type TBP is likely to
diminish, but not eliminate, the impact of the mutants.
Indeed many mutants displayed dominant growth pheno-
types (Figure S3 of Additional data file 1). Validating the use
of TBP mutants in the context of wild-type TBP, a nonlethal
TBP mutation generates similar genome-wide expression
profiles in the presence or absence of endogenous wild-type
TBP (Figure S4a, subpanel 4, of Additional data file 1). There-
fore, the presence of wild-type TBP in the background is not
expected to substantially impact the correlations between
simulated and actual data.
It was not feasible to eliminate all TBP regulatory interactions
via mutagenesis of TBP. First, since TBP's interaction surface
with SAGA remains ill-defined, this interaction was elimi-
nated by deleting SPT3, which encodes a TBP regulatory sub-
unit of SAGA [40,41]. Second, TBP mutations that impair
interactions with TFIID do not generate the same phenotype
as deletion of TFIID's main TBP interaction domain, the TAF1
TAND domain [16,17,42-45]. Since this region of TBP
interacts with other factors as well, we opted to delete the
TAND domain as a means to diminish TBP-TFIID interac-
tions. Third, we cannot be certain that the mutations affect
only the interactions being modeled, and thus is a caveat of
any in vivo analysis. However, the mutated residues
employed in our study have been biochemically characterized
for their defective interactions [27,42,46-48]. In the context
of our study, we sought to provide further evidence on a
genome-wide scale that the mutants were generally having
the intended effects in vivo. These validation studies are pre-
sented in section 2 of Additional data file 1, and support the
assertion that the mutants are defective in the modeled
interactions.
Identifying genes that are sensitive to the TBP 
regulatory network
Changes in mRNA output at more than 99% of all known S.
cerevisiae genes were measured in 63 wild-type or mutant
strains (Additional data file 2). Of these, 2,903 genes met
stringent filtering criteria for changes in gene expression (see
Materials and methods) and thus were chosen for the mode-
ling studies. Most of the remaining approximately 3,000
genes were not significantly expressed (cluster 0 in Table 1,
entry 12), which may be due to repressive mechanisms (for
example, repressors, chromatin, and so on) that lie outside of
the TBP regulatory network. Their lack of expression can be
modeled by setting the forward flux constants to zero. The
TBP regulatory network may be applicable to these genes
under conditions where they are expressed.
Individually applying the core mechanism to each of the
2,903 filtered genes was not practical. Instead we sought to
identify major themes in the network. This was achieved by
combining data from similarly behaving genes. Data consoli-
dation enhanced the robustness of modeling since any one
consolidated value is derived from as many as several hun-
dred data points that were not appreciably different from
each other (20% average standard deviation; see Additional
data file 2). We used a K-means algorithm to assist in cluster-
ing the data, and identified ten as the maximum number of
nonredundant clusters (Figure 3). Since all genome-wide
measurements naturally fall into a continuum of values
rather than well-partitioned clusters, the choice of a cluster
number is necessarily subjective. Partitioning the data into
more clusters generated increasingly subtle quantitative dif-
ferences rather than major qualitatively distinct patterns.
Genes within a cluster were consolidated by calculating
median changes in gene expression for each mutant in each
cluster.
Of the ten clusters, six (clusters 3-6 and 8-9) were deemed
appropriate for modeling studies. The properties of the
remaining four clusters (clusters 1, 2, 7 and 10) suggested that
they arose from indirect effects. The complex interconnectiv-
ity of biological systems ensures that some changes in gene
expression in response to a genetic perturbation will
necessarily cause other genes to change in expression, with
the latter being largely an indirect consequence of the pri-
mary perturbation. Therefore, indirect responders are not
accurate metrics of a perturbed network. Detailed justifica-
tions for their exclusion are presented in section 3 of Addi-
tional data file 1, which is briefly summarized here.
Cluster 1 values were inversely correlated with cluster 8 val-
ues (Figure S5 in Additional data file 1). The behavior of clus-
ter 8 could be accounted for by well known biochemical
interactions that TBP engages in. Accounting for the pattern
in cluster 1 as a direct effect of TBP required TBP to possess
biochemical activities that are the opposite of its known activ-
ities. Since there is no basis for such supposition, we interpretGenome Biology 2007, 8:R46


















Significance values relating genomic properties to clusters defined by the TBP regulatory network*
Cluster number†
Row‡ Property 0 1 2 3 4 5 6 7 8 9
Environmental stress
1 Induced during heat stress -25 -6 ... 8 ... 30 35 ... ... ...
2 Repressed during heat stress -7 106 ... ... ... ... ... ... ... ...
Gene ontology§
3 RB genes¶ ... 69 ... ... ... ... ... ... ... ...
4 RP genes¶ ... ... ... ... -4 ... ... ... 31 14
5 Oxidative phosphorylation {GO:6119} ... ... ... ... ... ... ... ... ... 13
6 Amine metabolism {GO:9308} ... ... ... 8 ... ... ... ... ... ...
7 Alcohol metabolism {GO:6066} ... ... ... 5 ... 9 4 ... ... ...
8 Energy derivation {GO:15980} ... ... ... ... ... 6 13 ... ... 5
9 Sporulation {GO:30435} ... ... ... ... 4 ... ... ... ... ...
10 Ty element transposition {GO:6319} ... ... ... ... ... ... ... 6 ... ...
11 Proteolysis {GO:6508} ... ... 6 ... ... ... ... ... ... ...
General properties
12 Lowly transcribed 84 ... ... ... 89 ... ... 10 ... ...
13 Highly transcribed ... ... ... ... -7 ... ... ... 12 21
14 Low mRNA levels 14 ... ... ... 28 -5 -6 ... ... ...
15 High mRNA levels -7 -6 ... ... -7 ... 32 ... 8 21
16 SAGA-dominated -46 ... ... 9 ... 53 43 ... ... ...
17 TATA-containing -52 -6 ... 9 12 45 46 ... ... 4
18 Low H3 K4Me2 in ORF ... ... ... ... 58 ... ... ... ... ...
19 Low H3 K4Me2 in IGR ... ... ... ... 28 ... ... ... ... ...
Positively regulated by
20 Spt3 (SAGA) -31 -4 -7 ... 28 5 31 28 ... ...
21 Mot1 ... ... ... ... -4 -6 ... ... 27 8
22 Bur6 (NC2) 13 15 ... ... ... -5 ... ... 17 ...
23 Bdf1 (TFIID) 11 ... ... ... ... ... ... 10 6 ...
24 Bdf2 ... ... ... ... 20 ... ... ... ... ...
25 TAF1 (TFIID) ... ... ... ... ... ... ... ... 10 5
Negatively regulated by
26 RP genes ... ¥ ... ... ... ... ... ... ... ...
27 Spt3 (SAGA) -8 6 27 30 ... ... ... -5 ... ...
28 Mot1 -25 ... ... 15 22 36 5 ... -6 ...
29 Bur6 (NC2) -28 ... ... 5 13 43 9 ... -4 ...
30 Bdf1 (TFIID) -21 ... ... 10 ... 25 8 ... ... ...
31 Hda1 -23 ... ... ... 25 11 5 5 ... ...
32 Tup1 (SSN6-TUP1) -31 ... -4 ... 52 12 11 17 ... ...
33 Set1 (COMPASS) -8 ... -6 ... 60 ... ... 15 ... ...
*Values represent -log10 p values, using the extreme most 10% of the data points (n > approximately 3,000) as identified in Additional data file 4, and 
are calculated using the CHITEST formula in EXCEL. Negative signs are inserted where relationships are anti-correlated. For clarity, any absolute 
value less than 4 was replaced with a period. †Cluster numbers refer to clusters shown in Figure 3. Cluster 0 includes all genes not clustered in 
Figure 3. ‡Row identifier in the text. References are provided in Additional data file 4. §Gene Ontology term identifier is provided in brackets. P 
values were derived using 'GO term finder' [62]. ¶RP genes are defined here as genes defined by the following Gene Ontology terms: ribosomal 
protein, mitochondrial ribosomal protein, translational elongation, translational initiation, translational termination, protein biosynthesis. RB genes 
are defined here by the following Gene Ontology terms: 35S primary transcript processing, ribosomal large subunit assembly and maintenance, 
rRNA metabolism, rRNA modification, rRNA processing, rRNA nucleus export, transcription from Pol I promoter, tRNA methylation, tRNA 
modification, tRNA processing, tRNA splicing, tRNA nucleus export, regulation of translation, processing of 20S pre-rRNA. ¥Up-regulated upon 
deletion of RPL12A (p < 10-24), RPL27A (p < 10-26), RPL34A (p < 10-8), RPL6B (p < 10-9), RPL8A (p < 10-63), or RPL24A (p < 10-20); see entries R135T, 
R137T, R138T, R139T, R140T, R141T in Additional data file 4.Genome Biology 2007, 8:R46
R46.8 Genome Biology 2007,     Volume 8, Issue 4, Article R46       Huisinga and Pugh http://genomebiology.com/2007/8/4/R46the inverse relationship between clusters 1 and 8 as cluster 8
genes being the predominant inhibitor of cluster 1 genes,
rather than TBP reversing its activity. Strikingly, cluster 8
genes encode predominantly ribosomal proteins whereas
cluster 1 genes are involved predominantly in ribosomal bio-
genesis (Table 1, rows 3 and 4), suggesting that ribosomal
protein genes or their products down-regulate ribosomal bio-
genesis genes. In support of this notion, cluster 1 genes are
highly enriched with genes that are up-regulated when ribos-
omal protein genes are deleted (Table 1, row 26).
Cluster 2 genes were up-regulated only in spt3Δ strains. How-
ever, ChIP-chip occupancy measurements indicated that Spt3
was not present at these genes in wild-type strains (data not
shown), suggesting that the changes in gene expression are
likely to be an indirect consequence of physiological adjust-
ments to the constitutive absence of Spt3. Cluster 7 genes
were down-regulated only in spt3Δ strains. Cluster 7 was
enriched with genes involved in Ty transposition (Table 1, row
10), which is particularly Spt3 dependent [49]. Because of the
possibility of unique regulation of Ty elements and the
potential for long-term physiological adjustments to the con-
stitutive spt3 deletion, cluster 7 genes were not modeled.
Almost all of cluster 10 genes were restricted to chromosomes
XI and XII (Figure S6 in Additional data file 1), suggesting
that the highly mutated strains that demarcate this cluster
underwent duplications of chromosomes XI and XII. There-
fore, the apparent increase in expression is likely due to an
increase in gene copy number, and thus was excluded from
the analysis.
Testing the TBP regulatory network through genome-
wide occupancy assays and expression profiling
Clusters 3-6 and 8-9 represent six classes of genes that dis-
play dependencies on different parts of the TBP regulatory
network. The challenge is to determine whether the flux con-
stants governing the network can be fit with values that reca-
pitulate these dependencies. A proper fit requires a match
between actual changes in gene expression, when a section of
the network is genetically impaired, and changes that are sim-
ulated when the relevant flux constant(s) is/are altered in
value. An important caveat here is that a good fit does not nec-
essarily indicate that the model is correct since there are more
degrees of freedom than there are observations to constrain
the model. Nevertheless, the modeling provides a tool for
integrating and interpreting massive genomic data sets into a
plausible conceptual model.
To enhance the accuracy of the modeling and assist in identi-
fying suitable values for the flux constants, we employed
additional types of data. First, the flux constants were empir-
ically set so as to recapitulate the relative transcription fre-
quencies that have been experimentally measured [3] for
genes in each of the six clusters. Next, we turned to measured
promoter occupancy levels of individual components of the
network using genome-wide ChIP-chip data [50]. We exam-
ined SAGA (Spt3 subunit), NC2 (Bur6 subunit), Mot1, TFIID
(TAF1, TAF5, TAF6, and TAF9 subunits), TBP, and pol II
(Rpb1, Rpb2, and Rpb7 subunits). For a particular cluster, the
flux constants governing the 16 reaction segments shown in
Figure 1 were adjusted such that a single set of values opti-
mally recapitulated the relative occupancy level of each of
these components as well as transcriptional output. Figure 4a
compares simulated versus actual levels of RNA output and
factor occupancy. The average correlation coefficient for
these relationships was 0.8, which indicates a good fit
between the model and the experimental data.
To simulate the experimental effect of each mutation that
perturbs the TBP regulatory network, the flux constants for
the relevant reaction segments were altered, and steady-state
RNA output reported (see Additional data file 3). We allowed
only those flux constants that are justifiably governed by the
interaction being mutated to change, and only in the direction
expected of the mutation, thereby constraining the degrees of
freedom. For example, the impact of the NC2-defective
TBP(F182V) mutation was simulated by reducing the flux
constant for reaction segments 8 and 11, which govern the
association of NC2 with TBP (illustrated in Figure 1). For mul-
tiple mutations, the relevant flux constants were set at or near
to the values for the single mutations allowing an approxi-
mate three-fold tolerance. This tolerance attempts to accom-
modate the possibility that one mutation might influence the
effect of other mutations.
Figure 4b compares simulated changes in RNA output upon
network perturbation to experimentally measured changes
when the network is perturbed by mutations. There was a
remarkable correspondence (R = 0.8), indicating that the
modeled changes can largely account for the experimentally
observed changes. To assess the specificity of modeling we
randomly assigned each set of cluster-specific values to a dif-
ferent cluster and re-ran the analysis. As expected, no sub-
stantial correlation was observed (data not shown),
indicating that the flux parameters for each cluster are likely
to generate a unique or limited number of solutions.
As a further test of the core mechanism illustrated in Figure 1,
we examined whether a simulated perturbation to the TBP
regulatory network could predict changes in TBP occupancy
at promoters measured by ChIP-chip. Figure 4c compares the
simulated and experimental data for changes in TBP occu-
pancy in a taf1(ΔTAND) strain harboring both wild-type TBP
and the TBP(F182V) mutation. With the exception of cluster
5, the simulation correlated with the experimental data (R =
0.56). The alternative outcome for cluster 5 illustrates the
value of the simulation, in that it suggests that the mechanism
and/or initialized flux constants need to be adjusted for clus-
ter 5 genes, and thus requires further investigation. Deviation
of the expression data from the simulated data for cluster 5 is
also apparent in Figure 4b (red symbols). Taken together, theGenome Biology 2007, 8:R46

















ncorrelations between the simulated and experimental data for
transcription frequency, ChIP-chip occupancy, and expres-
sion profiling suggest that the core mechanism illustrated in
Figure 1 is a plausible prototype of the genome-wide TBP reg-
ulatory network.
A TBP regulatory network tailored to sets of genes
Given the ability of the core mechanism to act as a template
for simulating the behavior of each cluster, we next tailored
the basic network model shown in Figure 1 to reflect actual
behavior. In Figure 5, each model is drawn to reflect the 'flow'
of TBP regulation that leads to PIC assembly and RNA pro-
duction. Thicker arrows and thicker lines denote higher levels
of flux through that portion of the network. We interpret
these models as follows: PIC assembly at cluster 9 is domi-
nated by the TFIID assembly pathway, and so the arrow gov-
erning TFIID association and the line representing the
promoter are drawn thicker. The SAGA pathway also partici-
Genome-wide changes in expression upon perturbation of the TBP regulatory networkFigure 3
Genome-wide changes in expression upon perturbation of the TBP regulatory network. We grouped 2,903 ORFs (rows) that changed expression by at 
least 1.5-fold in at least one of the 63 conditions (columns) examined into 10 clusters using the K-means algorithm [63]. Clusters 1-10 contained the 
following number of ORFs, respectively: 338, 333, 225, 330, 344, 359, 259, 282, 127, 306; 3,323 ORFs did not meet the filtering criteria. Changes are 
relative to a galactose-induced null TBP in a wild-type TBP background. Red, green, and black denote increased, decreased, and no change in gene 
expression. Gray denotes no data. Color intensity reflects the magnitude of change on a log2 scale. Columns were arranged by hierarchical clustering [63]. 
Color boxes above each column indicate the relevant strain genotypes. All mutations are located on TBP except where designated 'spt3Δ', and 'ΔTAND', 
which signify deletion of SPT3 and the TAF1 TAND domain. Boxes with dashed outlines indicate null TBP. All strains harbor a chromosomal copy of the 
endogenous wild-type TBP gene (SPT15).
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R46.10 Genome Biology 2007,     Volume 8, Issue 4, Article R46       Huisinga and Pugh http://genomebiology.com/2007/8/4/R46pates in cluster 9 but contributes little to RNA production
because NC2 and Mot1 shunt this pathway in a nonproductive
direction. Cluster 6 on the other hand is dominated by the
SAGA pathway, possibly due to the presence of a TATA box at
these genes (Table 1, row 17) that is linked to the SAGA path-
way [23]. Cluster 8 is dominated by the nonproductive TBP
pathway. Here, NC2 and Mot1 function positively in tran-
scription by dismantling this inhibitory pathway. Cluster 4
genes are lowly expressed due in part to blockage of TBP by
dimerization and TAF1 TAND interactions.
This TBP regulatory network accommodates much of the bio-
chemical, genetic, and genomic data on TBP, making it partic-
ularly compelling and useful for rationalizing the functional
significance of the clustering patterns and predicting experi-
mental outcomes. In particular, the network has the following
features. First, it allows the three assembly pathways (TFIID,
Testing the TBP regulatory network through genome-wide occupancy and expression profilingFigure 4
Testing the TBP regulatory network through genome-wide occupancy and expression profiling. (a) Correlations in RNA and factor occupancy levels, 
comparing simulated and experimental data. The flux constants governing the core reaction mechanism in Figure 2a were initialized to values specific to 
clusters 3, 4, 5, 6, 8, and 9 (Additional data file 3). The simulation was run to steady-state. RNA output and the levels of promoter-bound SAGA (Spt3), 
NC2 (Bur6), Mot1, TFIID (TAF1, TAF5, TAF6, TAF9), and PIC (Rpb1, Rpb2, Rpb7) were reported. These values were then compared to experimentally 
measured levels of RNA (transcription frequency as defined by [3], and the indicated factor occupancy measured by ChIP-chip [50,52]). Experimental 
values are median values for each of the six clusters (hence six data points). The x and y axes are on a linear scale. The units for each plot are relative, and 
thus have no intrinsic meaning except to provide a linear scale demarcating the relative concentration of RNA or promoter-bound species. Correlation 
coefficients (R) are indicated in the lower right corner of each plot. (b) Correlations between simulated and actual changes in RNA output when the TBP 
regulatory network is perturbed. The scatter plot reflects changes in actual (from Figure 3) and simulated RNA output relative to a wild-type cell. Median 
values for each mutant in each of the six clusters are plotted. Cluster 5 data are shown in red. The x and y axes are plotted on a linear scale, with values 
log2-transformed. The correlation coefficient (R) of all data is shown. (c) Simulated versus actual changes in occupancy of a TBP mutant that is defective in 
NC2 interactions. Production of HA-tagged TBP(F182V) in a wild-type TBP, taf1(ΔTAND) background was induced with galactose. After 45 minutes, cells 
were subjected to formaldehyde crosslinking. TBP was immunopurified and Cy3- or Cy5-labeled ChIP DNA was hybridized to yeast intergenic 
microarrays. The hybridization control reference used galactose-induced HA-tagged wild-type TBP in a taf1(ΔTAND) background, processed in parallel 
with TBP(F182V). Since the experimental set-up included both endogenous wild-type TBP and TBP(F182V) in the same cell, the simulation simultaneously 
ran the mechanism in duplicate in which the first mechanism was initialized with parameters for wild-type TBP and the second mechanism with parameters 
used to simulate the F182V mutation (Additional data file 3). The output being compared is the occupancy level of TBP(F182V) relative to TBP(WT). The 
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nSAGA, and nonproductive) illustrated in Figure 5 to operate
in competition and, therefore, influence each other. Hence,
regulation of the SAGA pathway can influence contributions
by the TFIID pathway. Second, when one pathway is
diminished, as in an spt3Δ strain, the other pathway is
allowed to compensate, providing a limited degree of func-
tional redundancy, as has been proposed for these two assem-
bly pathways [21,22]. Third, inhibitors of TBP, such as Mot1
and NC2, can produce a net negative or net positive effect (or
no effect) on transcription, as has been observed [25,26,33],
depending upon which of the three assembly pathways pre-
dominately governs RNA output. Importantly, the model pro-
vides predictive power for designing, conceptualizing and
analyzing genome-wide expression and ChIP microarray data
as it relates to the TBP regulatory network.
The 'flow' of PIC assembly through the TBP regulatory network at different gene clustersFigure 5
The 'flow' of PIC assembly through the TBP regulatory network at different gene clusters. Each assembly model corresponds to the indicated cluster 
number in Figure 3. The same prototype model described in Figure 1 is applied to all clusters. Line and arrow thickness reflect the magnitude of flux 
through the system.Genome Biology 2007, 8:R46
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nDesign logic behind the TBP regulatory network
As demonstrated here, the flow of the TBP regulatory network
is not uniform for all genes. Rather, it is tailored to specific
genes. The question arises as to whether this tailoring is ran-
domly placed or whether genes involved in a specific process
utilize the TBP regulatory network in the same way. To
address whether genes within a cluster have related func-
tions, we examined if any of approximately 1,500 genome-
wide properties that characterize yeast genes were particu-
larly enriched within each cluster (Additional data file 4). A
selected subset of these relationships is presented in Table 1.
Most clusters were enriched with genes that belonged to a
particular cellular process (rows 3-11). For example, cluster 4
was enriched with sporulation genes and cluster 8 with
ribosomal protein (RP) genes. Thus, genes involved in the
same process tend to be regulated by the TBP regulatory net-
work in the same way. Below, we summarize some insights
into the design logic.
RP genes encode physical components of the ribosome and
are quintessentially TFIID-regulated and TATA-less
[22,23,51]. However, computer modeling of RP-enriched
cluster 8 genes (Figure 5, as well as the data in Figure 3) sug-
gest that they are not only positively regulated by SAGA
(Spt3) but are also positively regulated by the TBP inhibitors
NC2 and Mot1. To assess the validity of these conclusions, we
turned to published genome-wide ChIP-chip occupancy data
of these factors and genome-wide expression profiles in NC2
and Mot1 mutants. Genome-wide promoter occupancy data
of Spt3 (SAGA), Bur6 (NC2), Mot1, TAF1 (TFIID), and TBP
[50,52] were transformed into percentile scores (ranging
from 0 to 1) so that their relative contribution across clusters
could be assessed. For each cluster from Figure 3 as well as for
RP and ribosomal biogenesis (RB) genes, the bar graphs in
Figure 6a display deviations from the genome-wide median
(defined as 0.5). Strikingly, compared to all other clusters, the
RP genes possessed the highest occupancy levels of SAGA,
NC2, and Mot1 (as well as TFIID). However, RP genes dis-
played a rather modest transcriptional dependency on SAGA,
NC2, and Mot1 (Figure 6b). Thus, the SAGA pathway assem-
bles at RP genes but contributes modestly to transcription of
these genes, which is consistent with the modeling of RP-
enriched cluster 8 and 9 (Figure 5).
Clusters 3, 5, and 6 were enriched with genes involved in dis-
tinct metabolic processes, including amine metabolism, alco-
hol/sterol metabolism, and energy production, respectively.
Genes in these clusters tended to rely on the more tightly con-
trolled SAGA pathway and were negatively regulated by NC2
and Mot1 to varying degrees, resulting in distinct flow
patterns in their assembly pathways (see Figure 5). The dis-
tinction between pathways 5 and 6 might indicate the pres-
ence of a regulatory step between TBP loading and PIC
assembly (see asterisks in Figure 5), which is in line with pre-
vious suggestions of post-recruitment regulation [53,54].
Cluster 4 genes are very lowly expressed during exponential
growth as might be expected of their enrichment with mid-
phase sporulation genes (Table 1, rows 9 and 12). These genes
appear to be inhibited in part by the functionally redundant
action of TBP dimerization and the TAF1 TAND domain, and
thus are related to cluster 4 in [42]. They tend to reside in the
repressive environment of subtelomeric regions, where they
are generally inhibited by the Hda1 histone deacetylase, the
Ssn-Tup1 complex, and the methyltransferase Set1 (Table 1,
rows 31-33). Cluster 4 genes, therefore, are likely to be main-
tained in a low transcriptional state by a variety of repression
mechanisms, including those in the TBP regulatory network.
The multiple levels of repression associated with cluster 4
genes might reflect the critical need to keep potentially
detrimental sporulation genes inactive during vegetative
growth. Consistent with their potential toxicity, any combina-
tion of mutants used in this study that resulted in elevated
expression of cluster 4 was also found to be toxic to cell
growth (Figure S3 in Additional data file 1).
The boundaries of SIR-mediated (Silent Information Regula-
tor) repression extending from telomeric into subtelomeric
regions along the chromosome are thought to be defined in
part by the counteraction of bromodomain factor Bdf1 [55].
Since cluster 4 genes typically reside in these regions [42], we
were surprised to find that they were not particularly
repressed by SIR proteins or activated by Bdf1. They were,
however, highly dependent upon BDF2 (Table 1, row 24),
which is the paralog of BDF1. Little is known about BDF2,
except that it is nonessential when BDF1 is present, and loss
of this gene affects the expression of very few genes [55-57].
The linkage between cluster 4 and genes that tend to be more
Bdf2-dependent provides a novel distinguishing feature
between Bdf1 and Bdf2. While Bdf1 might be specialized to
counteract SIR-mediated repression [55], in addition to its
function with TFIID, Bdf2 might be particularly suited to
operate in repressive environments that do not involve SIR
repression.
Properties of clusters 1-10 and RP and RB genesFigure 6 (see previous page)
Properties of clusters 1-10 and RP and RB genes. (a) Bar graph comparison of promoter occupancy levels for Spt3, Bur6, Mot1, and Taf1 [50,52]. Values 
correspond to median percentile scores for each indicated gene group or cluster after subtracting the genome-wide median (defined as 0.5), and thus 
represent deviations from the median. RP and RB genes are explicitly defined in Table 1. (b) Bar graph plotting median changes in gene expression for each 
of the indicated gene groups or clusters in the presence of the indicated mutants.Genome Biology 2007, 8:R46
R46.14 Genome Biology 2007,     Volume 8, Issue 4, Article R46       Huisinga and Pugh http://genomebiology.com/2007/8/4/R46Conclusion
The study presented here suggests how the TBP regulatory
network might be constructed. Rather than TBP regulators
functioning equivalently at all genes or selectively at nonover-
lapping sets of genes, they take on net negative or positive
roles depending upon many factors, including whether TFIID
or SAGA regulation predominates, and where the rate-deter-
mining step lies. Importantly, a single TBP regulatory net-
work is applicable genome-wide, with genes involved in
related biological processes being regulated by specific nodes
in the network. Gene-specific regulators are likely to control
the 'flow' of assembly through specific nodes. This TBP regu-
latory network is necessarily part of a much larger global gene
regulatory network that includes regulation of activators,
chromatin, and transcription elongation.
Materials and methods
Strains and plasmids
All strains were derived from Y13.2 (MATα ura3-52 trp1Δ-63
leu2, 3-112 his3-609 taf145Δ pYN1-TAF1) [58]. The wild-type
and ΔTAND strains have been previously described [42]. The
spt3Δ and ΔTAND spt3Δ strains were constructed as deriva-
tives of the above strains by replacement of the endogenous
SPT3 gene with a PCR amplified kanMX cassette through
homologous recombination [59]. Single mutant plasmids car-
rying the galactose inducible version of TBP on a CEN/ARS
plasmid have been previously described or were constructed
by site-directed mutagenesis from the wild type [47]. Double
and triple mutant combinations were constructed by stand-
ard sub-cloning methods from the single mutant plasmids or
by using site-directed mutagenesis when there were no suita-
ble restriction enzyme sites available. The 2u version of the
wild-type TBP plasmid was constructed through sub-cloning
by exchanging a ScaI/ClaI fragment containing the CEN/
ARS replication origin with a ScaI/ClaI fragment containing
the 2u origin found in the pRS425 plasmid. This created
p2uLF-yTBP(wt)(GAL10), which the various TBP mutants
were introduced into by sub-cloning. All newly created plas-
mids were verified by sequencing.
Cell growth for microarrays and immunoblot analysis
Transformants carrying the TBP plasmids were grown in
CSM-Leu-Trp + 3% raffinose liquid media until they reached
an OD600 = 0.65-0.8. Aliquots were removed (-galactose) for
immunoblot analysis (Figure S2 in Additional data file 1).
Expression of the TBP was induced by addition of galactose to
a final concentration of 2%. The wild-type and ΔTAND strains
contained the CEN/ARS version of the plasmids, which was
induced for 45 minutes while the spt3Δ and ΔTAND spt3Δ
strains carried the 2u version of the plasmids, which was
induced for three hours. After induction, an aliquot (+ galac-
tose) was removed prior to harvest. Anti-yTBP immunoblot-
ting was performed on the -/+ galactose aliquots to monitor
expression of the endogenous and Gal-inducible TBPs.
Microarray expression analysis
Genome-wide changes in mRNA levels were measured using
microarrays containing spotted PCR products of every open
reading frame (ORF). The reference sample for all arrays was
a wild-type strain expressing a null TBP that was treated iden-
tically and in parallel with the test samples. Cell harvesting,
RNA extraction, and hybridization was performed as
described previously [42]. Expression analyses of all test ver-
sus reference combinations were repeated at least twice,
incorporating a dye-swap of the test and reference samples,
with mRNA isolated from two independent transformants
(biological replicates). Data were mode normalized and fil-
tered for significant changes in gene expression essentially as
described [42]. First, the signal intensities for each channel,
as determined by subtracting the background median from
the foreground mean signal, was required to be greater than 1
standard deviation above the local background signal. Sec-
ond, ratios changed in the same direction in each replicate.
Third, the average log ratio of replicates was at least two
standard deviations from the mean ratio for that gene in the
homotypic data set. The value used for the standard deviation
was the greater of either the gene specific standard deviation
or the pooled (all genes) standard deviation. Fourth, p values
of the average log ratio when compared to the homotypic data
set were <0.005. These criteria resulted in very few false pos-
itives when applied to independent homotypic experiments.
Figure 3 included additional filters: fifth, fold changes in gene
expression were >1.5; and sixth, data were present in 60% of
the 63 experiments for any gene. Processed data are available
in Additional data file 2. A portion of the data from Figure 3
was obtained from [42,48]. Raw data are accessible at GEO
[60] under series accession number GSE7385. Expression
data for bur6-1 and mot1-14 was obtained from [25,30].
Genome-wide ChIP-chip analysis
Cell growth for TBP(F182V) ChIP-chip analysis was identical
to cell growth for the expression analysis. After the 45 minute
galactose induction, cultures were immediately crosslinked at
25°C for 2 h with 1% formaldehyde. The test strain contained
TBP(F182V) and the reference strain contained wild-type
TBP, both in a taf1(ΔTAND) strain harboring endogenous
wild-type TBP. Two biological replicates were hybridized to
microarrays containing spotted PCR amplified intergenic
regions, as described [23], with the following modifications.
Sonication was performed for 18 sessions and after removal
of an input sample. Galactose-induced TBP was immunopre-
cipitated with hemagglutinin (HA) antibodies. Signal intensi-
ties were calculated as described for expression arrays and
filtered to remove any spots whose signal in either channel
was less than one standard deviation above local background.
The data for promoter-containing intergenic regions was nor-
malized by setting the log2 ratio of all nonpromoter contain-
ing intergenic regions (tail-to-tail regions) equal to zero,
followed by averaging the normalized log2 ratios of replicates.Genome Biology 2007, 8:R46

















nGenome-wide occupancy data for SAGA (Spt3), NC2 (Bur6),
Mot1, TFIID (TAF1, TAF5, TAF6, TAF9), and pol II (Rpb1,
Rpb2, Rpb7) were obtained from [50,52]. Occupancy values
are defined as the ratio of the chIP signal/control signal,
where the control represents signal generated from nonspe-
cific contamination of genomic DNA during immunoprecipi-
tation using the method described in reference [61].
Relationship analysis
The relationships to the top and bottom 10% of the expression
and ChIP-chip distributions (Additional data file 4) were cal-
culated in Excel with the data downloaded from the refer-
enced lab or journal's websites. The percent rank of the
distribution was calculated with the PERCENTRANK
function. Then the number of genes that appear in the top
10% (>0.9 in PERCENTRANK) or the bottom 10% (<0.1 in
PERCENTRANK) and appear in each cluster were calculated.
The CHITEST function of Excel was then used to calculate p
values from the observed and expected values. P values for
rows 5-11 in Table 1 were calculated by GO term finder at the
Saccharomyces Genome Database [62].
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a PDF contain-
ing supporting text and figures. Additional data file 2 is an
Excel workbook that contains the log2 ratios of fold changes in
gene expression for the data shown in Figure 3 (63 × 6,227
expression ratios), the standard deviation of each cluster, and
ChIP-chip log2 ratios of occupancy relative to wild-type TBP
for experiments that were not published elsewhere (that is,
Figure 4c). Additional data file 3 is an Excel workbook con-
taining the flux constant values for each cluster and the prod-
ucts of the simulation. Additional data file 4 is an Excel
workbook containing p values for overlapping relationships
between gene clusters described here and a large amount of
published genomic data.
Additional data file 1Supporting text and figures.Click here for file 2Log2 ratios f fo d changes in gene expression for the data shown in Figure 3, tandard eviatio of each clu ter and C IP-chip l g2 ratios f ccup ncy relative t  wild-type TBP experiments that were not published elsewh re(63 × 6,227 xp si n ratios), the standard deviation of e ch cluster, and C IP-chip l g2 i  of occupancy rel t ve to il -type TBP for xperim nts th  were n t publish  el ewhere (that s, Fi u e 4c). 3ux stant v lu s fo  each cluster and the roducts of t  simul ti n. 4P v lues fo  over appi  r latio hip  b w e  g n  clust rsdesc ibed he n  a la g  am n  of ublishe genomic da a.
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